XML 185 R17.htm IDEA: XBRL DOCUMENT
v3.22.2.2

INTANGIBLE ASSET IMPAIRMENT AND OTHER COSTS | 9 Months Ended
--- | ---
Sep. 30, 2022
Restructuring and Related Activities [Abstract] |
INTANGIBLE ASSET IMPAIRMENT AND OTHER COSTS | INTANGIBLE ASSET IMPAIRMENT AND OTHER COSTS Intangible asset impairment and other costs for the three and nine months ended September 30, 2022 and 2021 were as follows:
Affected Line Item in the Consolidated Statements of Operations |  | Three Months Ended |  | Nine Months Ended
(in millions) |  | 2022 |  | 2021 |  | 2022 |  | 2021
Cost of products sold |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (3) |
Selling, general, and administrative expenses |  | — |  |  | 3 |  |  | — |  |  | 6 |
Intangible asset impairment and other costs |  | 97 |  |  | 3 |  |  | 107 |  |  | 11 |
Total intangible asset impairment and other costs |  | $ | 97 |  |  | $ | 6 |  |  | $ | 107 |  |  | $ | 14 |
For the three and nine months ended September 30, 2022, the above costs include an impairment charge of $94 million related to indefinite-lived tradenames and trademarks within the Technologies & Equipment segment and the Consumables segment. For more information on this impairment charge, refer to Note 14 Goodwill and Intangible Assets. Other costs for these periods include severance and other expense related to the Company's restructuring plans. The Company’s restructuring accruals at September 30, 2022 were as follows:
|  | Severance
(in millions) |  | 2020 and Prior Plans |  | 2021 Plans |  | 2022 Plans |  | Total
Balance at December 31, 2021 |  | $ | 5 |  |  | $ | 9 |  |  | $ | — |  |  | $ | 14 |
Provisions |  | 1 |  |  | 1 |  |  | 8 |  |  | 10 |
Amounts applied |  | (3) |  |  | (5) |  |  | (3) |  |  | (11) |
Change in estimates |  | (1) |  |  | — |  |  | — |  |  | (1) |
Balance at September 30, 2022 |  | $ | 2 |  |  | $ | 5 |  |  | $ | 5 |  |  | $ | 12 |
|  | Other Restructuring Costs
(in millions) |  | 2020 and Prior Plans |  | 2021 Plans |  | 2022 Plans |  | Total
Balance at December 31, 2021 |  | $ | 4 |  |  | $ | — |  |  | $ | — |  |  | $ | 4 |
Provisions |  | 1 |  |  | 1 |  |  | 1 |  |  | 3 |
Amounts applied |  | (4) |  |  | (1) |  |  | (1) |  |  | (6) |
Balance at September 30, 2022 |  | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | 1 |
The cumulative amounts for the provisions and adjustments and amounts applied for all the plans by segment were as follows:
(in millions) |  | December 31, 2021 |  | Provisions |  | Amounts Applied |  | Change in Estimates |  | September 30, 2022
Technologies & Equipment |  | $ | 7 |  |  | $ | 3 |  |  | $ | (6) |  |  | $ | — |  |  | $ | 4 |
Consumables |  | 11 |  |  | 7 |  |  | (8) |  |  | (1) |  |  | 9 |
All Other |  | — |  |  | 3 |  |  | (3) |  |  | — |  |  | — |
Total |  | $ | 18 |  |  | $ | 13 |  |  | $ | (17) |  |  | $ | (1) |  |  | $ | 13 |
The associated restructuring liabilities are recorded in Accrued liabilities and Other noncurrent liabilities in the Consolidated Balance Sheets.

X
- Definition The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported. + References No definition available. + Details
Name: | us-gaap_AssetImpairmentChargesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration